Relmada Therapeutics, Inc.

Industry

  • Pharmaceuticals
    • Drug Delivery
      • Controlled Release
    • Vaccines
    • Specialty Pharmaceuticals
  • Biotechnology

Other Names/Subsidiaries

  • Camp Nine
  • TheraQuest
See more in Biomedtracker

Latest on Relmada Therapeutics, Inc.

Scrip

Deal Watch: Eyenovia Looks At New Direction In Proposed Merger With Betaliq

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Eyenovia, Betaliq Will Have Combined C

Scrip

Deal Watch: FTC Keeps Current Merger Guidelines In Place, For Now

 
• By Joseph Haas

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Trump Appointee Ferguson Keeps Biden-E

Scrip

The Tourette’s Deal That Came Too Late To Save Sweden’s Asarina

 
• By Kevin Grogan

The directors of Asarina Pharma have finally found a buyer for the Tourette’s syndrome treatment sepranolone after securing a bittersweet deal with US firm Relmada Therapeutics which comes four months

Scrip

Finance Watch: As Cash Dwindles, Biotechs Cut Costs, Sell Assets, Merge, Assess Options

 
• By Mandy Jackson

The end of 2024 brought near-term cash shortfalls into focus at several biopharmaceutical companies, while others completed their assessments of potential alternatives to shutting their doors as capit